Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,322,732
-
Share change
-
-831,881
-
Total reported value
-
$22,659,000
-
Price per share
-
$9.76
-
Number of holders
-
34
-
Value change
-
-$11,360,859
-
Number of buys
-
17
-
Number of sells
-
22
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q2 2021
As of 30 Jun 2021,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,322,732 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MOORE CAPITAL MANAGEMENT, LP, MORGAN STANLEY, STATE STREET CORP, FORMULA GROWTH LTD, and Duquesne Family Office LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.